Kenneth E Kokko, MD - Medicare Nephrology in Chattanooga, TN

Kenneth E Kokko, MD is a medicare enrolled "Internal Medicine - Nephrology" physician in Chattanooga, Tennessee. He went to Emory University School Of Medicine and graduated in 1994 and has 30 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Yium, Shenouda And Miller Ptrshp, Yium, Shenouda And Miller Ptrshp and his current practice location is 251 N Lyerly St Ste 100, Chattanooga, Tennessee. You can reach out to his office (for appointments etc.) via phone at (423) 702-7904.

Kenneth E Kokko is licensed to practice in Tennessee (license number 55580) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1174533178.

Contact Information

Kenneth E Kokko, MD
251 N Lyerly St Ste 100,
Chattanooga, TN 37404-2743
(423) 702-7904
(423) 826-8010



Physician's Profile

Full NameKenneth E Kokko
GenderMale
SpecialityNephrology
Experience30 Years
Location251 N Lyerly St Ste 100, Chattanooga, Tennessee
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Kenneth E Kokko attended and graduated from Emory University School Of Medicine in 1994
  NPI Data:
  • NPI Number: 1174533178
  • Provider Enumeration Date: 08/09/2006
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 7810042181
  • Enrollment ID: I20170809004019

Medical Identifiers

Medical identifiers for Kenneth E Kokko such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174533178NPI-NPPES
116728MedicaidAL
02858713MedicaidMS
156543MedicaidAL
P01233207OtherMSRAILROAD MEDICARE
Q027635MedicaidTN

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology 040709 (Georgia)Secondary
207RN0300XInternal Medicine - Nephrology 20740 (Mississippi)Secondary
207RN0300XInternal Medicine - Nephrology 55580 (Tennessee)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Dci LafayetteLa fayette, GADialysis facility
Dci Fort OglethorpeFort oglethorpe, GADialysis facility
Erlanger Medical CenterChattanooga, TNHospital
Parkridge Medical CenterChattanooga, TNHospital
Memorial Healthcare System, IncChattanooga, TNHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Yium, Shenouda And Miller Ptrshp327451003739
Yium, Shenouda And Miller Ptrshp327451003739

News Archive

Researchers reveal how relatively unknown pathogen led to current Zika outbreak

An analysis comparing the individual differences between over 40 strains of Zika virus (30 isolated from humans, 10 from mosquitoes, and 1 from monkeys) has identified significant changes in both amino acid and nucleotide sequences during the past half-century.

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.

Photodynamic therapy could be useful in eradicating tumor-associated lymphatic vessels

Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer patients. One of the least studied routes of metastasis is the lymphatic system. Many tumors produce factors that promote the formation of new lymphatic vessels (lymphangiogenesis).

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Kenneth E Kokko allows following entities to bill medicare on his behalf.
Entity NameYium, Shenouda & Miller Ptrshp
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1972548089
PECOS PAC ID: 3274510037
Enrollment ID: O20040630000796

News Archive

Researchers reveal how relatively unknown pathogen led to current Zika outbreak

An analysis comparing the individual differences between over 40 strains of Zika virus (30 isolated from humans, 10 from mosquitoes, and 1 from monkeys) has identified significant changes in both amino acid and nucleotide sequences during the past half-century.

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.

Photodynamic therapy could be useful in eradicating tumor-associated lymphatic vessels

Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer patients. One of the least studied routes of metastasis is the lymphatic system. Many tumors produce factors that promote the formation of new lymphatic vessels (lymphangiogenesis).

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Kenneth E Kokko is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Kenneth E Kokko, MD
251 N Lyerly St Ste 100,
Chattanooga, TN 37404-2743

Ph: (423) 702-7904
Kenneth E Kokko, MD
251 N Lyerly St Ste 100,
Chattanooga, TN 37404-2743

Ph: (423) 702-7904

News Archive

Researchers reveal how relatively unknown pathogen led to current Zika outbreak

An analysis comparing the individual differences between over 40 strains of Zika virus (30 isolated from humans, 10 from mosquitoes, and 1 from monkeys) has identified significant changes in both amino acid and nucleotide sequences during the past half-century.

Auxilium Pharmaceuticals gets exclusive right to market VIVUS's STENDRA in the US and Canada

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.

Photodynamic therapy could be useful in eradicating tumor-associated lymphatic vessels

Tumor cells have several routes that enable them to move from the primary tumor to distant tissues, a process called metastasis. It is metastasis of the primary tumor that kills most cancer patients. One of the least studied routes of metastasis is the lymphatic system. Many tumors produce factors that promote the formation of new lymphatic vessels (lymphangiogenesis).

National clinical trial examines new option for kidney cancer patients

The trial, which opened last September, offers research subjects who qualify a new, targeted therapy in addition to standard immune therapy. The drug combination is being studied in a national Phase II clinical trial led by OHSU Cancer Institute researcher Christopher Ryan, M.D., through the Southwest Oncology Group, one of the largest clinical trial cooperative groups in the United States.

Read more News

› Verified 6 days ago


Internal Medicine Doctors in Chattanooga, TN

Dr. Pamela Rani Sud, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 725 Glenwood Drive, Suite E-500, Chattanooga, TN 37404
Phone: 423-495-2635    Fax: 423-495-2638
David Shved, D.O.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 975 E 3rd St, Chattanooga, TN 37403
Phone: 423-778-5179    Fax: 423-778-2108
Megan J Coylewright, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 975 E 3rd St, Chattanooga, TN 37403
Phone: 423-778-8258    
Dr. Charles Robert Bosshardt, M.D.
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 2515 Desales Ave Ste 206, Chattanooga, TN 37404
Phone: 423-698-8101    Fax: 423-698-3450
Dr. Elise Helene Marshall, DO
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 605 Glenwood Dr Ste 300, Chattanooga, TN 37404
Phone: 423-495-2690    Fax: 423-495-2698
Dr. Joshua Warner Hornsby, M.D.
Nephrology
Medicare: Medicare Enrolled
Practice Location: 979 E 3rd St Ste A-440, Chattanooga, TN 37403
Phone: 423-778-2867    Fax: 423-778-2866
Dr. Donald Franklin Mackler, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 721 Glenwood Dr, Ste. W552, Chattanooga, TN 37404
Phone: 423-629-6258    Fax: 423-629-9531

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.